Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4626
CALL
Freshpet
FRPT
$3.5B
| $290K | ﹤0.01% |
+7,900
| New | +$260K |
|
4627
Flotek Industries
FTK
$1.25B
| $290K | ﹤0.01% |
20,117
+4,114
| +26% | +$63.7K |
|
|
CHS
4628
PUT
DELISTED
Chicos FAS, Inc.
CHS
| $290K | ﹤0.01% |
33,400
-2,700
| -7% | -$24K |
|
4629
Cushman & Wakefield Ltd
CWK
$3.37B
| $289K | ﹤0.01% |
+17,008
| New | +$304K |
|
4630
PUT
Element Solutions
ESI
$9.51B
| $289K | ﹤0.01% |
23,200
-500
| -2% | -$6.24K |
|
|
GBT
4631
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $289K | ﹤0.01% |
7,600
-34,700
| -82% | -$1.54M |
|
|
MNTX
4632
DELISTED
Manitex International, Inc.
MNTX
| $289K | ﹤0.01% |
27,464
+24,969
| +1,001% | +$291K |
|
4633
Imperial Oil
IMO
$64B
| $288K | ﹤0.01% |
8,889
+2,095
| +31% | +$67.2K |
|
4634
CALL
Olin
OLN
$2.17B
| $288K | ﹤0.01% |
11,200
-4,000
| -26% | -$117K |
|
4635
Agilysys
AGYS
$3.25B
| $287K | ﹤0.01% |
17,605
+11,400
| +184% | +$183K |
|
4636
Camden National
CAC
$996M
| $287K | ﹤0.01% |
6,589
+5,328
| +423% | +$241K |
|
4637
Ardmore Shipping
ASC
$707M
| $286K | ﹤0.01% |
44,081
+41,683
| +1,738% | +$294K |
|
4638
CALL
Coca-Cola Europacific Partners
CCEP
$47.5B
| $286K | ﹤0.01% |
6,300
+900
| +17% | +$38.3K |
|
4639
Hyster-Yale Materials Handling
HY
$617M
| $286K | ﹤0.01% |
4,635
+3,030
| +189% | +$192K |
|
|
TELL
4640
DELISTED
Tellurian Inc.
TELL
| $286K | ﹤0.01% |
31,916
+25,991
| +439% | +$214K |
|
4641
CALL
JB Hunt Transport Services
JBHT
$26.5B
| $285K | ﹤0.01% |
2,400
+2,100
| +700% | +$256K |
|
|
TGH
4642
DELISTED
Textainer Group Holdings limited
TGH
| $285K | ﹤0.01% |
22,282
+15,654
| +236% | +$230K |
|
|
OTIC
4643
DELISTED
Otonomy, Inc.
OTIC
| $284K | ﹤0.01% |
103,632
-42,728
| -29% | -$137K |
|
|
TSG
4644
DELISTED
The Stars Group Inc.
TSG
| $284K | ﹤0.01% |
11,438
-7,962
| -41% | -$242K |
|
4645
Abeona Therapeutics
ABEO
$361M
| $283K | ﹤0.01% |
883
+738
| +509% | +$262K |
|
|
APTS
4646
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $283K | ﹤0.01% |
16,156
+10,579
| +190% | +$184K |
|
4647
CALL
United Therapeutics
UTHR
$21.5B
| $281K | ﹤0.01% |
2,200
+700
| +47% | +$86.6K |
|
4648
Ingersoll Rand
IR
$32.7B
| $280K | ﹤0.01% |
9,854
-150,469
| -94% | -$4.22M |
|
|
SJIU
4649
DELISTED
South Jersey Industries, Inc.
SJIU
| $280K | ﹤0.01% |
5,000
| – | – |
|
4650
CALL
CenterPoint Energy
CNP
$26.7B
| $279K | ﹤0.01% |
10,100
-13,800
| -58% | -$387K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.